Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ArQule prepares novel protein kinase inhibitors

July 29, 2011

CNIO patents novel protein kinase pim inhibitors

July 29, 2011

New dual IGF-I receptor/IR inhibitor is active in models of multiple myeloma

July 29, 2011

Sunshine Biopharma completes preclinical mechanism of clearance study of lead anticancer product

July 28, 2011

Enrollment complete in phase III trial of perifosine/capecitabine in colorectal cancer

July 28, 2011

Merck KGaA team discloses novel PDK1 inhibitors

July 28, 2011

Sanlugen prepares novel cytarabine prodrugs

July 28, 2011

TM-400 receives FDA orphan drug status

July 27, 2011

TH-302 and bevacizumab enter clinical trial in astrocytoma

July 27, 2011

Hutchison MediPharma patents new HGF receptor inhibitors

July 27, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...